Products & Alliances
PrEP Biopharm Ltd
hVIVO Innovation Areas
Challenge Study Services
Target & Biomarker Discovery
Aim Rule 26
Press and Media Contact
experimental influenza virus challenge
human monoclonal antibody
hVIVO challenge model
influenza disease model
TCN-032; anti-M2e antibody; influenza viral challenge. influenza rsearch
Scientific Papers: influenza
Scientific Paper 77 : The threat of avian influenza H5N1: ‘do we have the tools for the job’?
Scientific Paper 99 : Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination.
Scientific Paper 98 : Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections.
Scientific Paper 105 : Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge.
Scientific Paper 93 : Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study.
Scientific Paper 87 : DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial.
Scientific Paper 104 : Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model.
Scientific Paper 83 : Flu – effect of vaccine in elderly care home residents: a randomized trial.
Scientific Paper 114 : Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
Scientific Paper 91 : Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.